← Back
Data updated: Mar 10, 2026
FLORIDA
Oncology
FLORIDA is a generic drug manufacturer focused on Oncology.
2020
Since
2
Drugs
-
Trials
9
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
OLOPATADINE HYDROCHLORIDE 2026-01-06
OLOPATADINE HYDROCHLORIDE 2025-07-14
ABIRATERONE ACETATE 2025-05-19
Manufacturing (CMC)
OLOPATADINE HYDROCHLORIDE 2025-02-28
OLOPATADINE HYDROCHLORIDE 2024-12-18
ABIRATERONE ACETATE 2024-10-28
Labeling
ABIRATERONE ACETATE 2024-08-22
Labeling
OLOPATADINE HYDROCHLORIDE 2024-08-07
Manufacturing (CMC)
OLOPATADINE HYDROCHLORIDE 2024-04-09
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2020-02-19
- Latest
- 2023-03-23
- Applications
- 2